|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1655 NORTH FORT MYER DRIVE, #850 |
Address2 | |
| City | ARLINGTON |
State | VA |
Zip Code | 22209 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 21687-12
|
||||||||
|
6. House ID# 345460000
|
||||||||
| TYPE OF REPORT | 8. Year | 2009 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Molly M. Myers Senior Vice President |
Date | 10/14/2009 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
The American Recovery and Reinvestment Act- Making supplemental appropriations for job preservation and creation, infrastructure investment, energy efficiency and science, assistance to the unemployed, state and local fiscal stabilization for FY ending 9/30/09 and for other purposes
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Mark |
Heesen |
|
|
|
Sumita |
Singh |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
S.344 Hedge Fund Transparency Act - requires hedge funds to register with the SEC. NVCA wants language clarification
S.1276 - The Private Fund Transparency Act of 2009, NVCA wants clarification language to exclude venture capital industry
HR 711 The Hedge Fund Advisor Registration Act of 2009: NVCA opposes any inclusion of venture capital industry in this bill.
Title IV - Registration of Advisors to Private Funds, oppose administration language to require venture firms to register with the SEC
with the SEC as investment advisors.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Treasury - Dept of, White House Office, Securities & Exchange Commission (SEC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Mark |
Heesen |
|
|
|
Sumita |
Singh |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 1935 to amend the IRS code of 1986 to provide for the treatment of partnership interests held by partners providing services. NVCA opposes change to the characterization of partnership interests for the venture capital industry.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
The SBIR/STTR Reauthorization Act supported Title II of the bill which would allow venture capital backed companies to compete for SBIR/STTR grants and other SBA Programs. HR 2965: Enhancing small business research and innovation act.: S1233: A bill to reauthorize and improve SBIR and STTR programs and for other purposes. Draft: Small Business Early Stage Investment Act of 2009.Allow venture backed companies to participate in SBIR/STTR grants and SBIR programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Small Business Adminstration (SBA), White House Office,
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code CPT
16. Specific lobbying issues
S515 Patent Reform Act of 2009 lobbied on provisions dealing with post grant opposition procedures; damage apportionment and inequitable conduct.
HR 1260 - Patent Reform Act of 2009 - amend title 35
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Patent & Trademark Office (PTO), Commerce - Dept of (DOC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Mark |
Heesen |
|
|
|
Sumita |
Singh |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR 1548 Pathways for Biosimilars Act; HR 3200 - America's Affordable Health Choices Act
HR 1427 Access to Life Saving Medicine Act; Promoting innovation and both bills would create pathway to FDA for approval of follow on biologics;
S726 - Promoting innovation and access to life-saving medicine act; S325 Affordable Health Choices Act
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
HR1 American Recovery and Reinvestment Act: S1213 - Patient Centered Outcomes Research Act of 2009; S1259 Patients Act of 2009; 1321 - Healthy Americans Act; Expand CER, improve feedback to physicians, patient outcomes and protect innovation
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Mark |
Heesen |
|
|
|
Sumita |
Singh |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
FDA Preemption - Working with Congress to draft legislation that would establish a regulatory and reimbursement road map for medical diagnosis
S540 and HR 1346 - Medical device Safety Act of 2009
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
|
Kelly |
Slone |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
HR 2212 Clean Energy Development Administration - to improve the DOE loan guarantee and provide additional options for deploying energy technologies. S: 949 - 21st century deployment act - Energy Bank;
HR 1698 to establish hte Green Bank to assist in the financing of qualified clean energy projects and energy efficiency projects.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Energy - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
|
Emily |
Baker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
HR 2454 The American Clean Energy Security Act of 2009. Legislation aimed at placing a cap on greenhouse emissions; implement a renewable energy electricity standard and accelerate the adoption of clean energy technologies.
S1462: The American Clean Energy Leadership Act to accelerate the introduction of new clean energy technologies
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Environmental Protection Agency (EPA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
|
Emily |
Baker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Support science, technology and mathematics(STEM) education funding for NSF. Fully fund the America Competes Act which authorized improvements for K-12 ungraduate, graduate and continuing ED in STEM education.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Personalized medicine - working with Congress to establish a regulatory path for advanced diagnostic products.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Kelly |
Slone |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Healthcare reform: support provisions to protect innovation with the overhaul of the healthcare system. NVCA supports America's Healthy Future Act of 2009(no bill #) specifically CER provisions and medical device.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Kelly |
Slone |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Immigration Reform:(no bill#) working with Congress on class of VISA for foreign born entrepreneurs.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jennifer |
Dowling |
|
|
|
Emily |
Baker |
|
|
|
Sumita |
Singh |
|
|
|
Mark |
Heesen |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |